Download FREE Report Sample
Download Free sampleTargeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Targeted RNA Sequencing Market contains market size and forecasts of Targeted RNA Sequencing in Global, including the following market information:
Global Targeted RNA Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Targeted RNA Sequencing market was valued at 1852.7 million in 2021 and is projected to reach US$ 7255.4 million by 2028, at a CAGR of 21.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exome Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Targeted RNA Sequencing include Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen and GENEWIZ. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Targeted RNA Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted RNA Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Targeted RNA Sequencing Market Segment Percentages, by Type, 2021 (%)
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Global Targeted RNA Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Targeted RNA Sequencing Market Segment Percentages, by Application, 2021 (%)
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Global Targeted RNA Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Targeted RNA Sequencing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted RNA Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Targeted RNA Sequencing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
